rs751012696
Variant summary
Our verdict is Likely pathogenic. Variant got 6 ACMG points: 6P and 0B. PM5PP3_Strong
The NM_001943.5(DSG2):c.889G>A(p.Asp297Asn) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000434 in 1,614,002 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. D297V) has been classified as Uncertain significance.
Frequency
Consequence
NM_001943.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
DSG2 | NM_001943.5 | c.889G>A | p.Asp297Asn | missense_variant | 8/15 | ENST00000261590.13 | |
DSG2 | XM_047437315.1 | c.355G>A | p.Asp119Asn | missense_variant | 9/16 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
DSG2 | ENST00000261590.13 | c.889G>A | p.Asp297Asn | missense_variant | 8/15 | 1 | NM_001943.5 | P1 | |
DSG2 | ENST00000682087.2 | n.720G>A | non_coding_transcript_exon_variant | 6/6 | |||||
DSG2 | ENST00000683614.2 | n.720G>A | non_coding_transcript_exon_variant | 6/7 |
Frequencies
GnomAD3 genomes ? AF: 0.0000131 AC: 2AN: 152148Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.00000802 AC: 2AN: 249388Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 135308
GnomAD4 exome AF: 0.00000342 AC: 5AN: 1461854Hom.: 0 Cov.: 35 AF XY: 0.00000275 AC XY: 2AN XY: 727228
GnomAD4 genome ? AF: 0.0000131 AC: 2AN: 152148Hom.: 0 Cov.: 33 AF XY: 0.0000135 AC XY: 1AN XY: 74300
ClinVar
Submissions by phenotype
Arrhythmogenic right ventricular cardiomyopathy Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | All of Us Research Program, National Institutes of Health | Dec 18, 2023 | This missense variant replaces aspartic acid with asparagine at codon 297 of the DSG2 protein. Computational prediction is inconclusive regarding the impact of this variant on protein structure and function (internally defined REVEL score threshold 0.5 < inconclusive < 0.7, PMID: 27666373). To our knowledge, functional studies have not been reported for this variant. This variant has been reported in two individuals affected with arrhythmogenic right ventricular cardiomyopathy (PMID: 20031616, 20857253). One of these individuals was homozygous for this variant (PMID: 20031616). This variant has been reported in an individual affected with arrhythmogenic cardiomyopathy (Carrillo-Aleman et al. 2019, doi: 10.1093/ehjci/jez110.005). Two relative carriers were also affected while another adult carrier was normal in the family. This variant has been identified in 3/280790 chromosomes in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. - |
Cardiomyopathy Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Color Diagnostics, LLC DBA Color Health | Dec 20, 2022 | This missense variant replaces aspartic acid with asparagine at codon 297 of the DSG2 protein. Computational prediction is inconclusive regarding the impact of this variant on protein structure and function (internally defined REVEL score threshold 0.5 < inconclusive < 0.7, PMID: 27666373). To our knowledge, functional studies have not been reported for this variant. This variant has been reported in two individuals affected with arrhythmogenic right ventricular cardiomyopathy (PMID: 20031616, 20857253). One of these individuals was homozygous for this variant (PMID: 20031616). This variant has been reported in an individual affected with arrhythmogenic cardiomyopathy (Carrillo-Aleman et al. 2019, doi: 10.1093/ehjci/jez110.005). Two relative carriers were also affected while another adult carrier was normal in the family. This variant has been identified in 3/280790 chromosomes in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. - |
Arrhythmogenic right ventricular dysplasia 10 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Invitae | Dec 24, 2022 | This sequence change replaces aspartic acid, which is acidic and polar, with asparagine, which is neutral and polar, at codon 297 of the DSG2 protein (p.Asp297Asn). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed at Invitae for this missense variant, however the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on DSG2 protein function. ClinVar contains an entry for this variant (Variation ID: 199804). This missense change has been observed in individual(s) with arrhythmogenic right ventriculardysplasia (ARVD) (PMID: 20031616, 20857253). This variant is present in population databases (rs751012696, gnomAD 0.006%). - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Apr 18, 2017 | The D297N variant in the DSG2 gene has been reported in association with ARVC (Bhuiyan et al., 2009; Tan et al., 2010). Bhuiyan et al. reported D297N as homozygous in a 36 year old male patient with ARVC. Also, one other patient diagnosed with ARVC was reported as heterozygous for the D297N variant but did not present with symptoms until after 50 years of age (Tan et al., 2010). Another variant at this same residue (D297G) and variants in nearby residues (K294E) have been reported in HGMD in association with ARVC (Stenson et al., 2014). Furthermore, D297N was not observed in approximately 6,000 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. However, Cox et al. reported the D297N substitution as an unclassified variant based on in silico predictors being inconsistent (Cox et al., 2011).In summary, while there have been at least two published reports indicating an association between the D297N variant and ARVC, additional evidence is needed to determine whether this variant is pathogenic or benign. - |
Cardiovascular phenotype Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 06, 2022 | The p.D297N variant (also known as c.889G>A), located in coding exon 8 of the DSG2 gene, results from a G to A substitution at nucleotide position 889. The aspartic acid at codon 297 is replaced by asparagine, an amino acid with highly similar properties. This alteration has been reported in individuals from arrhythmogenic right ventricular cardiomyopathy (ARVC) cohorts, including one homozygous case and one case with an additional PKP2 variant detected (Bhuiyan ZA et al. Circ Cardiovasc Genet, 2009 Oct;2:418-27; Tan BY et al. J Cardiovasc Transl Res, 2010 Dec;3:663-73; Cox MG et al. Circulation, 2011 Jun;123:2690-700). This variant has also been detected in a cardiomyopathy genetic testing cohort; however, clinical details were limited, and additional cardiac variants were detected (van Lint FHM et al. Neth Heart J, 2019 Jun;27:304-309). This amino acid position is highly conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at